Kaiser Permanente union workers poised to strike after contract expires

Kaiser Permanente union workers poised to strike after contract expires


A sign is posted on the exterior of the Kaiser Permanente Vallejo Medical Center on September 08, 2023 in Vallejo, California.

Justin Sullivan | Getty Images

More than 75,000 workers at the largest nonprofit private health-care provider in the United States are poised to strike Wednesday after negotiations failed to reach an agreement over the weekend.

The workers’ contract with Kaiser Permanente expired Saturday with disagreements still simmering over staffing levels, which unions have made a focus of their demands, along with better pay and benefits.

The Coalition of Kaiser Unions on Monday accused Kaiser of negotiating in bad faith and committing unfair labor practices.

Workers will strike Wednesday morning if Kaiser executives do not take “dramatic action now to solve the Kaiser short staffing crisis by investing in its workforce,” the coalition said in a statement to CNBC.

The strike will target hundreds of Kaiser facilities across California, Colorado, Oregon, Washington, Virginia, and Washington D.C., according to the coalition.

Kaiser Permanente serves nearly 13 million patients. The nonprofit operates 39 hospitals and more than 600 medical offices across eight states and D.C.

CNBC Health & Science

Read CNBC’s latest health coverage:

The Coalition of Kaiser Permanente Unions’ membership includes medical assistants, surgical and lab technicians, pharmacists and administrative staff among other health-care workers.

A Kaiser spokesperson on Monday said that negotiations are ongoing, and previously said it remains optimistic an agreement will be reached and that a strike will be averted.

Kaiser also has said it has contingency plans to ensure patients continue to receive care during a strike.

Short staffing, a long-standing problem in the health-care sector, has led to unsafe wait times for patients and deteriorating care at Kaiser facilities, the union says.

“Kaiser executives refuse to acknowledge how much patient care has deteriorated or how much the frontline healthcare workforce and patients are suffering because of the Kaiser short-staffing crisis,” Dave Regan, president of SEIU-United Healthcare Workers West, said late last month

Kaiser reported a profit of $2 billion in the second quarter this year, compared to a loss of $1.2 billion in the same period in 2022.

The nonprofit generated $25 billion in revenue in the second quarter of this year.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More